Infloc

Sodium fusidate, the active ingredient in Infloc, is a fusidic acid antibiotic presented as a topical formulation for cutaneous use. It treats skin infections such as impetigo, folliculitis and secondary bacterial infections of dermatitis in patients requiring topical therapy.

GNH USA supplies Infloc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infloc, a fusidic acid antibiotic, is applied to bacterial skin infections. - Impetigo: reduces bacterial load and promotes healing of superficial skin lesions. - Folliculitis: eliminates the causative Staphylococcus organisms and alleviates inflammation. - Secondary bacterial infections of dermatitis: controls bacterial overgrowth and prevents worsening of dermatitis lesions.

Adverse reactions may occur with topical use of Infloc.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Itching: localized pruritus. - Burning sensation: transient warmth or stinging. - Dryness: flaking or scaling of the skin. - Rash: erythematous macular eruption. - Contact dermatitis: localized allergic response.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or angioedema. - Stevens‑Johnson syndrome: severe mucocutaneous necrosis. - Toxic epidermal necrolysis: extensive skin detachment. - Severe dermatitis: widespread inflammation. - Systemic hypersensitivity: fever, malaise, or organ involvement. - Anaphylaxis: rapid onset of life‑threatening symptoms.

When using Infloc, consider the following safety measures. - Allergy assessment: verify no known hypersensitivity to fusidic acid or formulation components. - Indication limitation: apply only to the specified skin infections. - Surface area restriction: avoid extensive application over large body areas. - Monitoring: watch for signs of worsening infection or systemic absorption, especially on compromised skin. - Avoid ocular use: do not apply to eyes or mucous membranes. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Potential drug interactions should be evaluated before prescribing Infloc.

Major Interactions (Avoid): - Concurrent systemic fusidic acid: may increase systemic exposure. - Topical corticosteroids: can mask infection signs and reduce efficacy. - Other topical antibiotics: possible antagonistic effects.

Moderate Interactions (Monitor Closely): - Silver‑containing dressings: may affect drug absorption. - Moisturizers or emollients: could dilute the concentration. - Phototherapy: may increase photosensitivity risk.